Cargando…
Re-orienting anti-malarial drug development to better serve pregnant women
Malaria is one of the most serious infectious diseases affecting predominantly low- and middle-income countries, where pregnant women are among the populations at risk. There are limited options to prevent or treat malaria in pregnancy, particularly in the first trimester, and existing ones may not...
Autores principales: | El Gaaloul, Myriam, Tornesi, Belen, Lebus, Flynn, Reddy, David, Kaszubska, Wiweka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003153/ https://www.ncbi.nlm.nih.gov/pubmed/35413907 http://dx.doi.org/10.1186/s12936-022-04137-2 |
Ejemplares similares
-
New developments in anti-malarial target candidate and product profiles
por: Burrows, Jeremy N., et al.
Publicado: (2017) -
Erratum to: New developments in anti-malarial target candidate and product profiles
por: Burrows, Jeremy N., et al.
Publicado: (2017) -
Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria
por: Macintyre, Fiona, et al.
Publicado: (2018) -
Improving the regulation of medical cannabis in Canada to better serve pediatric patients
por: Huntsman, Richard J., et al.
Publicado: (2021) -
CRIMALDDI: platform technologies and novel anti-malarial drug targets
por: Vial, Henri, et al.
Publicado: (2013)